Dynavax Technologies Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| MRK | Merck | Outperform |
2
|
$127.51 | $130.51 | 12.15% | 11 | $322.96B |
| PFE | Pfizer | Outperform |
2
|
$27.81 | $32.87 | 9.67% | 6 | $157.48B |
| SAN | Sanofi | Outperform |
16
|
91.30€ | 102.80€ | 19.39% | 9 | 114.00€B |
| GSK | GSK | Outperform |
12
|
£17.34 | £17.30 | 12.46% | 12 | £70.69B |
| GILD | Gilead Sciences Inc | Outperform |
11
|
$64.78 | $87.82 | 23.49% | 14 | $80.78B |
| MRNA | Moderna | Outperform |
16
|
$125.00 | $135.42 | 1.12% | 1 | $47.90B |
| 4502 | Takeda Pharmaceutical Company | Outperform |
5
|
¥4.13k | ¥4.74k | 10.30% | 0 | ¥6.47T |
| BNTX | BioNTech | Outperform |
12
|
$92.72 | $123.75 | 8.58% | 3 | $22.34B |
| NVAX | Novavax | Outperform |
11
|
$4.93 | $23.25 | 123.12% | 4 | $603.61M |
| VBIV | VBI Vaccines | Outperform |
10
|
$0.59 | $6.00 | 747.46% | 0 | $18.02M |